Nutrition
Biryani and Portion Control
Biryani doesn't need to disappear from your life to lose weight. Here is a practical, honest approach to portion and fre...
CLA has been a fixture in gym supplement stacks for over two decades, sold on the promise that it reduces body fat while preserving muscle.
Pooled trial data puts the effect at 1.08 kg. The researchers who produced that figure concluded there is insufficient evidence to recommend it.
There is also a safety question that deserves more attention than it gets.
What CLA is
CLA stands for conjugated linoleic acid, a group of fatty acids found naturally in beef, lamb and dairy products, particularly from grass-fed animals.
The supplement version is not extracted from those foods. It is manufactured by chemically altering safflower or sunflower oil, which produces a different mix of CLA isomers than occurs naturally.
That distinction matters more than it sounds, and it comes up again in the safety section.
Where the reputation came from
CLA's popularity traces to animal research from the 1980s and 1990s. In mice, CLA produced substantial reductions in body fat.
The effect in rodents was real and reproducible. The problem is that mice are not people, and the doses used relative to body weight were far higher than anything a human supplement delivers.
This pattern recurs throughout the supplement field. A compound performs impressively in animals, the marketing arrives immediately, and human trials produce a fraction of the effect years later.
What the human evidence shows
A systematic review and meta-analysis of randomised placebo-controlled trials, published on PubMed, pooled 67 trials of dietary supplements containing isolated organic compounds.
CLA produced a weight reduction of 1.08 kg compared with placebo, with a confidence interval from −1.61 to −0.55 and a p-value below 0.01.
So the effect is statistically solid. It is also small.
The analysis used a threshold of 2.5 kg or more for clinical significance. CLA did not meet it. Neither did any other compound examined.
The authors' conclusion was direct: there is currently insufficient evidence to recommend any of these dietary supplements for weight loss.
That is the assessment of researchers who read all 67 trials, and it is worth more than any individual product's marketing copy.
How CLA compares
| Supplement | Pooled weight effect |
|---|---|
| Chitosan | 1.84 kg |
| Green tea extract | 1.78 kg |
| Glucomannan | 1.27 kg |
| CLA | 1.08 kg |
| Garcinia cambogia | 0.88 kg |
| Berberine | No significant change |
| Clinical significance threshold | 2.5 kg |
Every one of these falls short.
For scale, semaglutide averaged 14.9 percent body weight reduction in STEP 1, roughly 13 kg on a 90 kg person.
The body composition claim
CLA is usually marketed on body composition rather than scale weight. The claim is that it reduces fat while preserving or increasing lean mass, so the scale may not move much while your shape changes.
Some trials do report modest reductions in fat mass. The effects are small, inconsistent between studies, and generally not large enough to be visible.
If a supplement genuinely recomposed your body, trials measuring body composition directly would show it clearly and consistently. They do not.
The safety concerns
This is the part that separates CLA from the merely ineffective supplements, and it gets remarkably little coverage.
Insulin resistance. Several studies have found CLA supplementation worsened insulin sensitivity, particularly the trans-10, cis-12 isomer that is enriched in commercial supplements but present only in small amounts in food. For anyone with prediabetes, type 2 diabetes or metabolic syndrome, a supplement that may worsen insulin resistance is working against the goal.
Liver effects. Case reports have described liver injury associated with CLA supplementation, and some animal studies show fat accumulation in the liver at high doses.
Inflammation markers. Some trials have found increases in markers of inflammation and oxidative stress.
Digestive effects. Nausea, loose stools and abdominal discomfort are commonly reported.
None of these are certainties, and the evidence is mixed rather than damning. But the risk-benefit calculation is unfavourable. A supplement delivering 1.08 kg does not have much room to absorb a plausible insulin resistance signal.
The isomer problem
Natural CLA from beef and dairy is mostly the cis-9, trans-11 isomer.
Manufactured supplement CLA typically contains roughly equal parts cis-9, trans-11 and trans-10, cis-12.
That second isomer is the one most associated with both the claimed fat loss effect and the insulin resistance concern. It is present in food only in trace amounts.
So the argument that CLA is safe because it occurs naturally in food does not hold. The supplement is not what is in the food.
CLA in Pakistan
CLA capsules are sold through gym supplement retailers and online sellers here, frequently as part of fat burner stacks combining several ingredients.
Multi-ingredient formulations are the greater concern. When CLA is combined with stimulants and undeclared compounds, neither the effect nor the risk can be predicted. WHO estimates at least 1 in 10 medical products in low- and middle-income countries are substandard or falsified, and supplements face even less oversight than medicines.
The underlying issue is the same one running through this entire category. CLA is proposed to affect how your body handles fat. It does nothing about how much you eat.
Appetite is what determines intake, and it is governed by gut hormone signalling rather than fatty acid metabolism. That is the pathway the METASLIM™ product page describes, a physician-reviewed sublingual supplement working on GLP-1 appetite signalling with a physician reviewing every order before dispatch. It is not a pharmaceutical GLP-1 receptor agonist and injectable trial figures do not apply to it. What distinguishes it from a fat burner capsule is regulation, medical screening, and acting on hunger rather than on fat metabolism at the margins.
See the range of medical weight loss options available locally. Our guides to glucomannan and berberine cover other widely sold supplements.
The verdict
CLA produced 1.08 kg weight loss in pooled randomised trial data, below the 2.5 kg clinical significance threshold.
The reviewing researchers concluded there is insufficient evidence to recommend it or any comparable supplement for weight loss.
Its body composition claims are not well supported by trials that measured composition directly.
It carries plausible concerns about insulin resistance and liver effects, driven largely by an isomer that is enriched in supplements but nearly absent from food.
For anyone with prediabetes or type 2 diabetes, the insulin signal makes it a poor choice specifically.
Find out what the program costs for an approach that addresses intake rather than fat metabolism.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified physician before starting any weight loss program, medication, or supplement.